Interventional Radiology, Radiology Department, University of São Paulo, Rua Rafael Rinaldi, 365, apto 603, Uberlândia, São Paulo, 38400-384, Brazil.
J Med Case Rep. 2024 Nov 4;18(1):534. doi: 10.1186/s13256-024-04845-0.
This study was designed to evaluate the clinical benefit of double-lumen port catheters in patients receiving chemotherapy and parenteral nutrition concurrently or in those with vascular access failure. The advantages, complications, indications and duration of use of double port-a-cath were considered.
Thirteen Brazilian patients received a double-lumen port catheter that was implanted under ultrasonographic and fluoroscopic guidance in the radiologic interventional suite.
All double-lumen port systems were successfully implanted in all patients without immediate complications. The port-a-cath was removed in two patients due to infection of the reservoir. Three deaths occurred due to underlying disease with no correlation to the port-a-cath. No temporal interference between the administration of chemotherapy and parenteral nutrition was observed.
The double-door approach is a safe technique with low complication rates. Indications for use of the dual port are numerous and should be encouraged because of the considerable benefits for critically ill patients.
本研究旨在评估双腔港导管在同时接受化疗和肠外营养或血管通路失败的患者中的临床获益。考虑了双端口港导管的优点、并发症、适应证和使用时间。
13 名巴西患者在放射介入套房中接受了超声和透视引导下植入的双腔港导管。
所有双腔港系统均成功植入所有患者,无即刻并发症。由于储液器感染,两名患者取出了港导管。三名患者因基础疾病死亡,与港导管无关。未观察到化疗和肠外营养给药之间的时间干扰。
双开门技术是一种安全的技术,并发症发生率低。双端口的适应证很多,应鼓励使用,因为它对危重病患者有很大的益处。